Kalaris Therapeutics Inc

KLRS

$ -

Review earnings summary, surprise history, and upcoming forecasts.

account_balance_walletEarnings Summary

Updated: 03/31/2026FY2026 Q1

Revenue (TTM)

0M USD

YoY -

Net Income (TTM)

-11M USD

YoY Expanded Deficit

Equity Ratio

62.4%

YoY +0.5pt

BPS

2.89$

YoY -81.7%

Revenue

FY2024 Q2$0

FY2024 Q3$0

FY2024 Q4$0

FY2025 Q1$0

FY2025 Q2$0

FY2025 Q3$0

FY2025 Q4$0

FY2026 Q1$0

Actual

YoY$0 (-)

Net Income

$-10.9M

FY2024 Q2$-9.1M

$-9.1M

FY2024 Q3$-47.1M

$-47.1M

Surprise History

Actual RevenueAnalyst Estimate

FY2021MISS

Actual:$0

Est:$382,500